Targeting PD-1/PD-L1 interactions for cancer immunotherapy

被引：293
|
作者：
Zitvogel, Laurence [1 ,2 ,3 ,4 ]
Kroemer, Guido [3 ,5 ,6 ,7 ,8 ]
机构：
[1] Inst Gustave Roussy, INSERM, U1015, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Ctr Clin Invest CBT507, Villejuif, France
[3] Inst Gustave Roussy, Villejuif, France
[4] Univ Paris 11, Villejuif, France
[5] INSERM, U848, Villejuif, France
[6] Ctr Rech Cordeliers, Paris, France
[7] Hop Europeen Georges Pompidou, Paris, France
[8] Univ Paris 05, Fac Med, Paris, France
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 08期
关键词：
CELL CARCINOMA PATIENTS; CLINICAL-SIGNIFICANCE; PD-1; PATHWAY; B7-H1; EXPRESSION; MOLECULE; IMMUNOSUPPRESSION; RECEPTORS; LIGAND-1; ANTIBODY;
D O I：
10.4161/onci.21335
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1223 / 1225
页数：3
相关论文
共 50 条
  • [31] PD-1/PD-L1 pathway: Basic biology and role in cancer immunotherapy
    Salmaninejad, Arash
    Valilou, Saeed Farajzadeh
    Shabgah, Arezoo Gowhari
    Aslani, Saeed
    Alimardani, Malihe
    Pasdar, Alireza
    Sahebkar, Amirhossein
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (10) : 16824 - 16837
  • [32] The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
    Wenxiao Jiang
    Shuya Pan
    Xin Chen
    Zhi-wei Wang
    Xueqiong Zhu
    Molecular Cancer, 20
  • [33] Small Molecules as PD-1/PD-L1 Pathway Modulators for Cancer Immunotherapy
    Jiao, Peifu
    Geng, Qiaohong
    Jin, Peng
    Su, Gaoxing
    Teng, Houyun
    Dong, Jinlong
    Yan, Bing
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (41) : 4911 - 4920
  • [34] The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
    Jiang, Wenxiao
    Pan, Shuya
    Chen, Xin
    Wang, Zhi-wei
    Zhu, Xueqiong
    MOLECULAR CANCER, 2021, 20 (01)
  • [35] PD-1 Targeting in Cancer Immunotherapy
    Ferris, Robert
    CANCER, 2013, 119 (23) : E1 - E3
  • [36] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [37] PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
    Liu, Jinhua
    Chen, Zichao
    Li, Yaqun
    Zhao, Wenjie
    Wu, JiBiao
    Zhang, Zhen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [38] Targeting the PD-1/PD-L1 axis for cancer treatment: a review on nanotechnology
    Tran, Tuan Hiep
    Tran, Thi Thu Phuong
    ROYAL SOCIETY OPEN SCIENCE, 2022, 9 (04):
  • [39] Immunotherapy Targeting PD-1/PD-L1 in Early-Stage Triple-Negative Breast Cancer
    Yang, Tinglin
    Li, Wenhui
    Huang, Tao
    Zhou, Jun
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (03):
  • [40] Advances of biphenyl small-molecule inhibitors targeting PD-1/PD-L1 interaction in cancer immunotherapy
    Chen, Roufen
    Yuan, Dandan
    Ma, JunJie
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (02) : 97 - 113
12345